| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/07/2009 | US20090118261 Quinazolinone derivatives and their use as b-raf inhibitors |
| 05/07/2009 | US20090118255 Crp Lowering Agent |
| 05/07/2009 | US20090118233 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 05/07/2009 | US20090118200 Proline bis-amide orexin receptor antagonists |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117074 Sulfonylpyrroles as Histone Deacetylase Inhibitors |
| 05/07/2009 | US20090114355 Organic fluorescent compositions |
| 05/07/2009 | CA2704336A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | CA2703915A1 P2x3 receptor antagonists for treatment of pain |
| 05/07/2009 | CA2703909A1 P2x3, receptor antagonists for treatment of pain |
| 05/07/2009 | CA2703718A1 Inhibitors of histone deacetylase |
| 05/07/2009 | CA2703257A1 Benzomorpholine derivatives and methods of use |
| 05/07/2009 | CA2702320A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto |
| 05/07/2009 | CA2700917A1 Novel pyrimidine derivatives |
| 05/07/2009 | CA2699889A1 4,4-disubstituted piperdines |
| 05/07/2009 | CA2699631A1 Pyridazinone compounds and p2x7 receptor inhibitors |
| 05/06/2009 | EP2055698A1 Chromene compound |
| 05/06/2009 | EP2054411A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 05/06/2009 | EP2054405A1 Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 05/06/2009 | EP2054395A2 Piperazine compounds with a herbicidal action |
| 05/06/2009 | EP2054392A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha |
| 05/06/2009 | EP2054388A1 Viral polymerase inhibitors |
| 05/06/2009 | EP2054385A2 Phenyl, pyridine and quinoline derivatives |
| 05/06/2009 | EP1670757B1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2009 | EP1670478A4 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase |
| 05/06/2009 | EP1613156B1 N-phenyl- " (4-pyridyl)- azinyl]amine derivatives as plant protection agents |
| 05/06/2009 | EP1599453B1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | EP1385506B1 Acylated piperidine derivates as melanocortin-4 receptor agonists |
| 05/06/2009 | EP1343782B1 Pyrimidineamines as angiogenesis modulators |
| 05/06/2009 | CN101426788A Substituted pyrazinone derivatives for use as a medicine |
| 05/06/2009 | CN101426780A Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/06/2009 | CN101426779A Pesticides containing a bicyclic bisamide structure |
| 05/06/2009 | CN101426775A Oxadiazolidinedione compound |
| 05/06/2009 | CN101426773A 5-phenyl-3-benzyl-oxazolidin-2-one derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders |
| 05/06/2009 | CN101426772A Benzotriazine inhibitors of kinases |
| 05/06/2009 | CN101426769A Five-membered heterocyclic invertebrate pest control agents |
| 05/06/2009 | CN101426766A Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101423515A Novel preparation method of Ezetimibe |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN100484935C Benzimidazole-derivatives as factor Xa inhibitors |
| 05/05/2009 | US7528404 Assembly of a semiconductor die attached to substrate with oxazoline derivative bearing an electron donor or acceptor functionality |
| 05/05/2009 | US7528167 Inhibitors of papilloma virus |
| 05/05/2009 | US7528160 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 05/05/2009 | US7528143 JAK family of protein tyrosine kinases inhibitors; N4-(4-Methoxy-phenyl)-N2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-pyrimidine-2,4-diamine; angiogenic-associated disorders including solid tumors and cancer, eye disease, inflammation, psoriasis, viral infection; antiproliferative agents |
| 05/05/2009 | US7528140 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors |
| 05/05/2009 | US7528137 Compounds, compositions, and methods |
| 05/05/2009 | US7528134 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 05/05/2009 | US7528130 Cytotoxic agents comprising taxanes and their therapeutic use |
| 05/05/2009 | US7528129 CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 04/30/2009 | WO2009055749A1 2-aminooxazole derivatives as trpvl antagonists useful for treating pain |
| 04/30/2009 | WO2009055519A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | WO2009055357A1 Diazepane compounds which modulate the cb2 receptor |
| 04/30/2009 | WO2009055289A2 Therapeutic substituted lactams |
| 04/30/2009 | WO2009054984A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/30/2009 | WO2009054923A2 Synthesis and crystalline forms of cb-1 antagonist/inverse agonist |
| 04/30/2009 | WO2009054794A1 Amino 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054793A1 Thiophene 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054792A1 Aminopyridine derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054791A1 Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054790A1 Amide linked heteroaromatic derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054787A1 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054786A1 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054785A1 1,2,4-triazole ether derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054468A1 Azolecarboxamide compound or salt thereof |
| 04/30/2009 | WO2009054423A1 Oxadiazolidinedione compound |
| 04/30/2009 | WO2009054202A1 Process for producing organic compound and organic compound obtained by the same |
| 04/30/2009 | WO2009053799A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 04/30/2009 | WO2009053694A1 Therapeutic oxy-phenyl-aryl compounds and their use |
| 04/30/2009 | WO2009053452A1 4,4-disubstituted piperidines |
| 04/30/2009 | WO2009053269A1 Novel kinase inhibitors |
| 04/30/2009 | WO2009031011A3 Xinafoate salt of n4-(2, 2-difluoro-4h-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-n2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine |
| 04/30/2009 | WO2009015037A3 5-pyridinone substituted indazoles |
| 04/30/2009 | WO2008140553A4 Mapk/erk kinase inhibitors |
| 04/30/2009 | WO2007058850A3 Inhibitors of akt activity |
| 04/30/2009 | US20090111983 Cycloalkylcarbonylamino Acid Derivative and Process For Producing The Same |
| 04/30/2009 | US20090111862 Compound |
| 04/30/2009 | US20090111854 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111824 Amide linked heteroaromatic derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111820 Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111819 New pyridazin-3(2h)-one derivatives |
| 04/30/2009 | US20090111811 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111810 Substituted pyrimidine-5-carboxamide and 5-carboxylic ester kinase inhibitors |
| 04/30/2009 | US20090111809 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/30/2009 | US20090111808 Novel histamine h3-receptor ligands and their therapeutic applications |
| 04/30/2009 | US20090111807 Novel 1,2,3,4-Tetrahydroquinoxaline Derivative Having Glucocorticoid Receptor Binding Activity |
| 04/30/2009 | US20090111806 Azaquinolone based compounds exhibiting prolyl hydroxylase Inhibitory activity, compositions, and uses thereof |
| 04/30/2009 | US20090111804 ARYLINDENOPYRIMIDINES AND THEIR USE AS ADENOSINE A2a |
| 04/30/2009 | US20090111803 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/30/2009 | US20090111802 Cyclocarbamate derivatives as progesterone receptor modulators |
| 04/30/2009 | US20090111801 Substituted pyrazinone derivatives for use as a medicine |
| 04/30/2009 | US20090111800 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/30/2009 | US20090111796 7-membered ring compound and method of production and pharmaceutical application thereof |
| 04/30/2009 | US20090111790 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 04/30/2009 | US20090111789 Chiral cis-imidazolines |
| 04/30/2009 | US20090111778 2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase |
| 04/30/2009 | US20090111151 Production of Polyketides |
| 04/30/2009 | DE102007047737A1 Piperidin- und Piperazinderivate Piperidine and piperazine derivatives |